Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2019-04-01
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remote Stimulation and Training to Advance Recovery From TBI in Seniors
NCT07332299
Neuromodulation of Cognition in Older Adults
NCT02137122
Home-based Exercise Via a Telecommunications System
NCT00248781
A rTMS and Virtual Reality Based Cognitive Rehabilitation Program for MCI
NCT06024473
Effects of Rapid-Resisted Exercise and Bright Light Therapy on Ambulatory Adults With Traumatic Brain Injury
NCT01175993
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: The study objective is to determine the effects of rTMS treatment of the dorsolateral prefrontal cortex compared to sham on: \[1. Short-term (2-wk) changes in executive function;\] 2. Long-term (24-wk) adherence to a home-based exercise program; 3. Long-term (24-wk) changes in balance and gait; and \[4. Short-term (2-wk) changes in self-efficacy and delay discounting.\]
Methods: Sedentary community-dwelling older Veterans (age 60 years and older, \[N=106\]) will participate in a double-blind randomized sham-controlled three-phase study. The proposed study will use Nintendo Wii-Fit exercises. Phase I will include two weeks of facility-based exercise for safety assessment and learning the program, followed by 12 weeks of home-based exercises. \[Subjects with poor adherence and those with good adherence with low EF\] will then be randomized to rTMS or sham treatments. Phase II will include ten consecutive weekdays of rTMS or sham treatment along with exercise training for subjects with poor adherence \[and for those with good adherence and low EF\] and continuation of home-based exercises for those with good adherence and EF. Phase III includes 24-weeks of a home-based exercise program. All subjects will exercise for 45 minutes five days/week. \[Objective measure of adherence collected from Wii-Fit console and Conner's continuous performance test for EF will be the primary outcome measures.\] Balance and gait will be assessed. \[Self-efficacy, delay discounting along with fear of falls, and falls incidence will be assessed. Outcome measures will be assessed at baseline, and at 14, 16, and 40 weeks.\]
Significance: This project may have a major impact in improving adherence to an exercise program and in turn, improve balance in sedentary community-dwelling older Veterans. Knowledge gained about the adherence to home-based exercises would be applicable to multiple conditions such as diabetes. Since Wii-Fit and rTMS are readily available, translation of the study results to clinical practice would be expeditious.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Repetitive Transcranial Magnetic Stimulator (rTMS) treatment and Nintendo Wii-Fit exercises arm
This group will be randomized to receive Repetitive Transcranial Magnetic Stimulator (rTMS) and Nintendo Wii-Fit exercises
Repetitive Transcranial Magnetic Stimulator
Participants randomized to this group will receive repetitive transcranial magnetic stimulation and will do Nintendo Wii-Fit exercises
Nintendo Wii-Fit exercises
Participants will do Nintendo Wii-Fit exercises
Sham treatment and Nintendo Wii-Fit exercises arm
This group will be randomized to receive sham treatment and Nintendo Wii-Fit exercises
Sham treatment
Participants randomized to this group will receive sham treatment and will do Nintendo Wii-Fit exercises
Nintendo Wii-Fit exercises
Participants will do Nintendo Wii-Fit exercises
Nintendo Wii-Fit exercises only arm
This group will not be randomized and receive only Nintendo Wii-Fit exercises
Nintendo Wii-Fit exercises
Participants will do Nintendo Wii-Fit exercises
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Repetitive Transcranial Magnetic Stimulator
Participants randomized to this group will receive repetitive transcranial magnetic stimulation and will do Nintendo Wii-Fit exercises
Sham treatment
Participants randomized to this group will receive sham treatment and will do Nintendo Wii-Fit exercises
Nintendo Wii-Fit exercises
Participants will do Nintendo Wii-Fit exercises
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have Television (TV) at home
* Subjects reporting spending long periods of time in sedentary behavior by answering affirmatively to the question: 'For most days, do you feel you sit for too long (6-8 hours or more a day)?
* Some examples might include when watching TV, working at the computer / laptop or when doing sitting-based hobbies such as reading and sewing' will be included
Exclusion Criteria
EXCLUSIONARY DUE TO Wii-Fit Exercises
* Use of wheel chair for mobility
* Cognitive impairment \[Montreal Cognitive Assessment (MoCA \< 26)\]
* Weight 325 lbs. (weight restriction of the Wii-Board)
* Absolute contraindications to exercise per The American College of Sports Medicine guidelines
* Those with medical conditions that in the opinion of the study physician are likely to compromise safe participation
EXCLUSIONARY DUE TO rTMS
* Taking medications known to increase risk of seizures from 2012 Beers criteria such as bupropion, chlorpromazine, clozapine.
* Taking other medications known to increase risk of seizures such as tricyclic antidepressants.
* Taking ototoxic medications: Aminoglycosides, CisplatinHistory of seizures/ seizures in first degree relatives
* Those with implanted device
* History of stroke, aneurysm, or cranial neurosurgery
* History of bipolar disorder
* History of abnormal electroencephalogram (EEG)
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kalpana P Padala, MD MS
Role: PRINCIPAL_INVESTIGATOR
Central Arkansas Veterans Healthcare System , Little Rock, AR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Central Arkansas Veterans Healthcare System , Little Rock, AR
Little Rock, Arkansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E2961-R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.